Legend Biotech Corp Adjustments For Increase Decrease In Trade And Other Payables
Legend Biotech Corp (LEGN) reported Adjustments For Increase Decrease In Trade And Other Payables of $44.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2026-03-10
- Legend Biotech Corp adjustments for increase decrease in trade and other payables for the quarter ending 2025-12-31 was -$15.90M, a 361.72% decline year-over-year.
- Legend Biotech Corp adjustments for increase decrease in trade and other payables for the quarter ending 2025-09-30 was $24.27M.
- Legend Biotech Corp adjustments for increase decrease in trade and other payables for the quarter ending 2025-06-30 was $16.52M.
- Legend Biotech Corp adjustments for increase decrease in trade and other payables for the quarter ending 2025-03-31 was $19.51M, a 14.41% decline year-over-year.
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 3 month | Adjustments For Increase Decrease In Trade And Other Payables 3 month as first filed | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 6 month as first filed | Adjustments For Increase Decrease In Trade And Other Payables 9 month | Adjustments For Increase Decrease In Trade And Other Payables 9 month as first filed | Adjustments For Increase Decrease In Trade And Other Payables 12 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$15.90M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $8.37M derived: sum of 2 quarters · filed 2026-03-10 | $24.89M derived: sum of 3 quarters · filed 2026-03-10 | $44.40M 20-F · filed 2026-03-10 | ||||
| 2025-09-30 | $24.27M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $40.79M derived: sum of 2 quarters · filed 2025-11-12 | $60.30M 6-K · filed 2025-11-12 | $66.38M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2025-06-30 | $16.52M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $36.03M 6-K · filed 2025-08-11 | $42.11M derived: sum of 3 quarters · filed 2026-03-10 | $29.29M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2025-03-31 | $19.51M 6-K · filed 2025-05-13 | $25.59M derived: sum of 2 quarters · filed 2026-03-10 | $12.77M derived: sum of 3 quarters · filed 2026-03-10 | $10.81M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-12-31 | $6.08M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$6.74M derived: sum of 2 quarters · filed 2026-03-10 | -$8.70M derived: sum of 3 quarters · filed 2026-03-10 | $14.10M 20-F · filed 2026-03-10 | $14.06M 20-F · filed 2025-03-11 | |||
| 2024-09-30 | -$12.82M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -$14.77M derived: sum of 2 quarters · filed 2025-11-12 | $8.02M 6-K · filed 2025-11-12 | $6.56M 6-K · filed 2024-11-12 | -$26.46M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-06-30 | -$1.95M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $20.84M 6-K · filed 2025-08-11 | $19.29M 6-K · filed 2024-08-09 | -$13.64M derived: sum of 3 quarters · filed 2026-03-10 | -$18.01M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-03-31 | $22.80M 6-K · filed 2025-05-13 | $19.30M 6-K · filed 2024-05-13 | -$11.68M derived: sum of 2 quarters · filed 2026-03-10 | -$16.05M derived: sum of 3 quarters · filed 2026-03-10 | -$24.32M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2023-12-31 | -$34.48M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$38.85M derived: sum of 2 quarters · filed 2026-03-10 | -$47.12M derived: sum of 3 quarters · filed 2026-03-10 | -$50.20M 20-F · filed 2026-03-10 | -$12.70M 20-F · filed 2024-03-19 | |||
| 2023-09-30 | -$4.37M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$12.64M derived: sum of 2 quarters · filed 2024-11-12 | -$15.72M 6-K · filed 2024-11-12 | $26.22M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | -$8.27M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$11.35M 6-K · filed 2024-08-09 | $30.59M derived: sum of 3 quarters · filed 2025-03-11 | $55.92M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | -$3.08M 6-K · filed 2024-05-13 | $38.86M derived: sum of 2 quarters · filed 2025-03-11 | $64.19M derived: sum of 3 quarters · filed 2025-03-11 | |||||
| 2022-12-31 | $41.94M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $67.27M derived: sum of 2 quarters · filed 2025-03-11 | $72.45M 20-F · filed 2025-03-11 | $25.85M 20-F · filed 2023-03-30 | ||||
| 2022-09-30 | $25.33M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $30.50M 6-K · filed 2023-11-20 | ||||||
| 2022-06-30 | $5.17M 6-K · filed 2023-08-15 | |||||||
| 2021-12-31 | $1.80M 20-F · filed 2024-03-19 | |||||||
| 2021-06-30 | $5.76M 6-K · filed 2021-08-23 | |||||||
| 2020-12-31 | -$4.35M 20-F · filed 2023-03-30 | |||||||
| 2020-06-30 | -$2.61M 6-K · filed 2021-08-23 | |||||||
| 2019-12-31 | $2.01M 20-F/A · filed 2023-02-17 | |||||||
| 2018-12-31 | $3.24M 20-F · filed 2021-04-02 |